C07H 21/00
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate
Official title: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
C07H21/00 (Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate) appears on 7,641 US grants and 9,244 published applications in this corpus.
Search patents in C07H- Granted patents
- 7,641
- Published applications
- 9,244
- Assignees
- 2,647
- Inventors
- 12,890
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 5 | 0 |
| 1978 | 5 | 0 |
| 1979 | 5 | 0 |
| 1980 | 10 | 0 |
| 1981 | 6 | 0 |
| 1982 | 11 | 0 |
| 1983 | 17 | 0 |
| 1984 | 14 | 0 |
| 1985 | 14 | 0 |
| 1986 | 12 | 0 |
| 1987 | 24 | 0 |
| 1988 | 28 | 0 |
| 1989 | 34 | 0 |
| 1990 | 24 | 0 |
| 1991 | 29 | 0 |
| 1992 | 56 | 0 |
| 1993 | 75 | 0 |
| 1994 | 49 | 0 |
| 1995 | 92 | 0 |
| 1996 | 156 | 0 |
| 1997 | 240 | 0 |
| 1998 | 282 | 0 |
| 1999 | 264 | 0 |
| 2000 | 239 | 0 |
| 2001 | 297 | 69 |
| 2002 | 243 | 324 |
| 2003 | 212 | 990 |
| 2004 | 233 | 842 |
| 2005 | 252 | 736 |
| 2006 | 281 | 395 |
| 2007 | 258 | 358 |
| 2008 | 272 | 301 |
| 2009 | 228 | 379 |
| 2010 | 291 | 307 |
| 2011 | 259 | 296 |
| 2012 | 230 | 280 |
| 2013 | 238 | 339 |
| 2014 | 233 | 296 |
| 2015 | 259 | 281 |
| 2016 | 252 | 330 |
| 2017 | 229 | 283 |
| 2018 | 203 | 277 |
| 2019 | 239 | 352 |
| 2020 | 222 | 314 |
| 2021 | 221 | 285 |
| 2022 | 180 | 275 |
| 2023 | 171 | 279 |
| 2024 | 169 | 236 |
| 2025 | 182 | 272 |
| 2026 | 92 | 148 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for use in treating dystrophic epidermolysis bullosa6 Oct 2026US 12,751,974 B2Osaka University
- Polyhydroxylated cyclopentane derivatives and methods of use29 Sep 2026US 12,747,257 B2Sanegene Bio USA Inc.
- Synthesis of oligomeric compounds comprising phosphorothioate diester and phosphodiester linkages29 Sep 2026US 12,747,260 B2Ionis Pharmaceuticals, Inc.
- MRNA 5′-end cap analogs modified within phosphate residues, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide29 Sep 2026US 12,747,261 B2Explorna Therapeutics Sp. z o.o.
- Alkoxyphenyl derivatives, protected nucleosides and protected nucleotides, method for producing oligonucleotides, and method for removing substituents29 Sep 2026US 12,747,262 B2Fujimoto Chemicals Co., Ltd.
- Synthesis of cap-2 mrna8 Oct 2026US 2026/0308652 A1Arizona Board of Regents on behalf of Arizona State University
- Therapeutic circular dna forms1 Oct 2026US 2026/0294957 A1Flagship Pioneering Innovations Vii, LLC
- Continuous oligonucleotide synthesizer and method for synthesizing oligonucleotide using the same1 Oct 2026US 2026/0295553 A1
- Devices and methods for synthesis1 Oct 2026US 2026/0297124 A1Twist Bioscience Corporation
- Methods and compositions for preparing nucleic acids that preserve spatial-proximal contiguity information24 Sep 2026US 2026/0285892 A1Arima Genomics, Inc.
Most cited
By later US patents
- Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof1,998US 5,143,854 AAffymax Technologies N.V. · 1992
- Uncharged morpholino-based polymers having achiral intersubunit linkages1,700US 5,034,506 AAnti-Gene Development Group · 1991
- Array of oligonucleotides on a solid substrate1,585US 5,445,934 AAffymax Technologies N.V. · 1995
- Neural regeneration peptides and methods for their use in treatment of brain damage1,465US 7,563,862 B2Neuren Pharmaceuticals Limited · 2009
- Arrays of materials attached to a substrate1,410US 5,744,305 AAffymetrix, Inc. · 1998